United States · Series B startup
4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$125Mraised across 4 rounds since 2013, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
OrbiMed
RA Capital Management
F-Prime Capital
New Leaf Venture Partners
Rock Springs Capital
Jennison Associates
Partner Fund Management (PFM)From a historical funding recordSEC filing: $65M sold, first sale Apr 2015
No investor was named in the report.
From a historical funding recordSEC filing: $25M sold, first sale Oct 2013
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Oct 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Dimension Therapeutics's investors include OrbiMed, F-Prime Capital, RA Capital Management, New Leaf Venture Partners and Fidelity Biosciences, and 4 more on record.
Dimension Therapeutics has raised $125M across 4 rounds since 2013.
Dimension Therapeutics's most recent round was a Series B of $65M in Apr 2015.
Its most recent round, $65M in Apr 2015, is also its largest on record.
Dimension Therapeutics's first round on record, in Jun 2014, was backed by OrbiMed, F-Prime Capital and Fidelity Biosciences.
Dimension Therapeutics's latest named round is a Series B, in Apr 2015.
Dimension Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·